What restricted share units (RSUs) does the Autolus (AUTL) CTO hold and how do they vest?

The CTO holds 83,300 restricted share units. These RSUs vest in four equal annual installments starting January 26, 2027. Each RSU represents a contingent right to receive one Autolus American Depositary Share as vesting conditions are satisfied over the scheduled period.

How are Autolus (AUTL) American Depositary Shares related to ordinary shares in this filing?

Each American Depositary Share referenced in the filing is convertible at any time, at the reporting person’s option, into one ordinary share. This one-to-one relationship simplifies understanding the CTO’s economic exposure across ADS holdings, options, and restricted share units.

Autolus CTO reports initial share and option holdings

Autolus Therapeutics plc filed an initial ownership report for Chief Technology Officer Neville Miranda Suzette.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Autolus Therapeutics plc filed an initial ownership report for Chief Technology Officer Neville Miranda Suzette. The filing shows direct ownership of 23,720 American Depositary Shares, each convertible into one ordinary share. Suzette also holds multiple share options to buy ADS at exercise prices between $1.46 and $16.02 expiring from 2030 to 2036, plus 83,300 restricted share units that vest in four equal annual installments starting on January 26, 2027, each RSU representing one ADS.

Insider Trade Summary

12 transactions reported

Mixed 12 txns

Insider Neville Miranda Suzette

Role Chief Technology Officer

Type	Security	Shares	Price	Value
holding	American Depositary Shares	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Restricted Share Units	--	--	--
holding	Share Option (right to buy)	--	--	--

Holdings After Transaction: American Depositary Shares — 23,720 contracts (Direct); Share Option (right to buy) — 1,432,000 contracts (Direct); Restricted Share Units — 83,300 contracts (Direct)

Footnotes (11)

F1. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
F2. Fully vested and exercisable.
F3. This option vested 25% on July 22, 2023 and the remainder vested or vests in 36 equal monthly installments thereafter.
F4. This option vested 25% on March 6, 2024 and the remainder vests in 36 equal monthly installments thereafter.
F5. This option vested 25% on October 12, 2024 and the remainder vests in 36 equal monthly installments thereafter.
F6. This option vested 25% on February 23, 2025 and the remainder vests in 36 equal monthly installments thereafter.
F7. This option vested 25% on March 14, 2026 and the remainder vests in 36 equal monthly installments thereafter.
F8. This option vests 25% on October 8, 2026 and the remainder vests in 36 equal monthly installments thereafter.
F9. This option vests 25% on January 26, 2027 and the remainder vests in 36 equal monthly installments thereafter.
F10. The restricted share units ("RSUs") vest in four equal annual installments commencing on January 26, 2027.
F11. Each RSU represents a contingent right to receive one Issuer American Depositary Share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Autolus (AUTL) Form 3 filing disclose about insider holdings?

The Form 3 shows Autolus CTO Neville Miranda Suzette’s existing equity stake, including 23,720 American Depositary Shares, multiple share option awards with various exercise prices and maturities, and 83,300 restricted share units that convert into ADS over time as they vest.

How many Autolus (AUTL) American Depositary Shares does the CTO hold directly?

The CTO directly holds 23,720 American Depositary Shares. Each ADS is convertible into one ordinary share of Autolus Therapeutics, giving a clear view of her current direct equity position separate from options and restricted share units detailed in the same filing.

What equity option awards are reported for the Autolus (AUTL) CTO?

The filing lists several share options to buy American Depositary Shares, with exercise prices ranging from $1.46 to $16.02 and expirations between 2030 and 2036. Individual grants include, for example, 375,000 ADS at $1.46 and 250,000 ADS at $1.73 per share.

Does the Autolus (AUTL) Form 3 show any insider buying or selling activity?

The Form 3 is an initial ownership report and does not show new purchases or sales. Instead, it summarizes the CTO’s existing direct ADS holdings, outstanding share options, and unvested restricted share units as of the reporting date, without recording transactional changes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 07:45 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Neville Miranda Suzette

(Last)

(First)

(Middle)

C/O AUTOLUS THERAPEUTICS PLC

THE MEDIAWORKS, 191 WOOD LN, WHITE CITY

(Street)

LONDON

W12 7FP

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Technology Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares	⁽¹⁾	⁽¹⁾	Ordinary Shares	23,720	⁽¹⁾	D
Share Option (right to buy)	⁽²⁾	08/17/2030	American Depositary Shares	15,000	$16.02	D
Share Option (right to buy)	⁽²⁾	03/17/2032	American Depositary Shares	11,900	$4.29	D
Share Option (right to buy)	⁽³⁾	07/22/2032	American Depositary Shares	50,000	$2.86	D
Share Option (right to buy)	⁽⁴⁾	03/06/2033	American Depositary Shares	35,100	$1.91	D
Share Option (right to buy)	⁽⁵⁾	10/12/2033	American Depositary Shares	250,000	$2.31	D
Share Option (right to buy)	⁽⁶⁾	03/01/2035	American Depositary Shares	250,000	$1.73	D
Share Option (right to buy)	⁽⁷⁾	03/14/2035	American Depositary Shares	325,000	$1.89	D
Share Option (right to buy)	⁽⁸⁾	10/08/2035	American Depositary Shares	100,000	$1.49	D
Share Option (right to buy)	⁽⁹⁾	01/26/2036	American Depositary Shares	375,000	$1.46	D
Restricted Share Units	⁽¹⁰⁾	⁽¹⁰⁾	American Depositary Shares	83,300	⁽¹¹⁾	D
Share Option (right to buy)	⁽²⁾	01/15/2031	American Depositary Shares	20,000	$9.02	D

Explanation of Responses:

1. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.

2. Fully vested and exercisable.

3. This option vested 25% on July 22, 2023 and the remainder vested or vests in 36 equal monthly installments thereafter.

4. This option vested 25% on March 6, 2024 and the remainder vests in 36 equal monthly installments thereafter.

5. This option vested 25% on October 12, 2024 and the remainder vests in 36 equal monthly installments thereafter.

6. This option vested 25% on February 23, 2025 and the remainder vests in 36 equal monthly installments thereafter.

7. This option vested 25% on March 14, 2026 and the remainder vests in 36 equal monthly installments thereafter.

8. This option vests 25% on October 8, 2026 and the remainder vests in 36 equal monthly installments thereafter.

9. This option vests 25% on January 26, 2027 and the remainder vests in 36 equal monthly installments thereafter.

10. The restricted share units ("RSUs") vest in four equal annual installments commencing on January 26, 2027.

11. Each RSU represents a contingent right to receive one Issuer American Depositary Share.

	/s/ Miranda Neville	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR